Zobrazeno 1 - 10
of 102
pro vyhledávání: '"J. Migas"'
Autor:
D. Schreeder, F. Badin, S. Dakhil, P. Lammers, M. Patel, D. Slater, J. Migas, N. Naveh, A. Boccuti, R. Hanvesakul, W. Li, B. Halmos
Publikováno v:
Journal of Thoracic Oncology. 18:e43
Autor:
P. Bushunow, S. Dakhil, P. Lammers, N. Naveh, A. Boccuti, R. Hanvesakul, W. Li, J. Migas, D. Slater, F. Badin, B. Halmos
Publikováno v:
Journal of Thoracic Oncology. 17:S145-S146
Autor:
G. Rocque, J.L. Blum, Y. Ji, T.J. Pluard, J. Migas, S. Lakhanpal, E. Jepsen, E. Gauthier, Y. Wang, M. Montelongo, J.C. Cappelleri, M.S. Karuturi, D. Tripathy
Publikováno v:
Annals of Oncology. 33:S659
Autor:
Debu Tripathy, Derrick W. Spell, Steven L. McCune, John J. Migas, Carrie L. Dul, Sharon Wilks, Yao Wang, Zhe Zhang, Joanne L. Blum, Aditya Bardia, Yuan Liu
Publikováno v:
Cancer Research. 81:LB033-LB033
Background POLARIS is an ongoing, prospective, real-world (RW) study of palbociclib (PAL) in patients (pts) with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer (HR+/HER2- ABC). A biomarker goal of
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
John J. Migas, S. Lakhanpal, Joanne L. Blum, Yunfei Wang, G. Comstock, Debu Tripathy, Sharon Wilks, Gabrielle B. Rocque, Joseph C. Cappelleri, Aditya Bardia, J Perkins
Publikováno v:
Cancer Research. 78:OT3-05
Background: P is a novel cyclin-dependent kinase 4/6 inhibitor approved in the United States and Canada in combination with endocrine therapy for HR+/human epidermal growth factor receptor 2–negative (HER2-) advanced breast cancer (ABC). Despite pr
Autor:
Mohamad Adham Salkeni, Derrick W. Spell, Joanne L. Blum, Bethany G. Sleckman, Yao Wang, Gabrielle B. Rocque, John J. Migas, Aldemar Montero, Sami Diab, Sharon Wilks, Debu Tripathy, Ibrahim Nakhoul, Joseph C. Cappelleri, Daniel M. Anderson
Publikováno v:
Journal of Clinical Oncology. 37:200-200
200 Background: Real-world practice patterns often differ from treatment in clinical trials. We assessed real-world standard-of-care treatment with palbociclib (PAL) in the context of previously reported PALOMA trial results. Methods: POLARIS is a pr
Autor:
Debu Tripathy, D.M. Anderson, Aditya Bardia, Mohamad Adham Salkeni, Steven L. McCune, J. Wang, John J. Migas, K. Patel, Joseph C. Cappelleri, S. Lakhanpal, G. Comstock, Gabrielle B. Rocque, Joanne L. Blum, Yao Wang
Publikováno v:
Annals of Oncology. 29:viii112-viii113
Autor:
Dziągwa-Becker, Magdalena1 (AUTHOR) m.dziagwa@iung.wroclaw.pl, Oleszek, Marta2 (AUTHOR) moleszek@iung.pulawy.pl, Zielińska, Sylwia3 (AUTHOR) sylwia.zielinska@umw.edu.pl, Oleszek, Wiesław2 (AUTHOR) wieslaw.oleszek@iung.pulawy.pl
Publikováno v:
Molecules. May2024, Vol. 29 Issue 10, p2247. 11p.
Autor:
Cuesta, Cristina Gómez1
Publikováno v:
Historia Actual Online. primavera2024, Issue 64, p39-56. 17p.